Cargando…
Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology
Resistance to programmed cell death (PCD) is a hallmark of cancer. While some PCD components are prognostic in cancer, the roles of many molecules can be masked by redundancies and crosstalks between PCD pathways, impeding the development of targeted therapeutics. Recent studies characterizing these...
Autores principales: | Mall, Raghvendra, Bynigeri, Ratnakar R, Karki, Rajendra, Malireddi, R K Subbarao, Sharma, Bhesh Raj, Kanneganti, Thirumala-Devi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623737/ https://www.ncbi.nlm.nih.gov/pubmed/36329783 http://dx.doi.org/10.1093/narcan/zcac033 |
Ejemplares similares
-
ZBP1 Drives IAV-Induced NLRP3 Inflammasome Activation and Lytic Cell Death, PANoptosis, Independent of the Necroptosis Executioner MLKL
por: Malireddi, R. K. Subbarao, et al.
Publicado: (2023) -
Inflammatory cell death, PANoptosis, screen identifies host factors in coronavirus innate immune response as therapeutic targets
por: Malireddi, R. K. Subbarao, et al.
Publicado: (2023) -
Whole-genome CRISPR screen identifies RAVER1 as a key regulator of RIPK1-mediated inflammatory cell death, PANoptosis
por: Malireddi, R.K. Subbarao, et al.
Publicado: (2023) -
PANoptosis components, regulation, and implications
por: Malireddi, R.K. Subbarao, et al.
Publicado: (2020) -
Role of inflammasomes/pyroptosis and PANoptosis during fungal infection
por: Briard, Benoit, et al.
Publicado: (2021)